All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ABYLY / Ablynx NV
|
|
|
|
|
|
|
|
| JD / JD.com, Inc. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| MSFT / Microsoft Corporation
|
|
|
|
|
|
|
|
| MS / Morgan Stanley
|
|
|
|
|
|
|
|
| DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| US0153511094 / Alexion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CORI / Corium International, Inc.
|
|
|
|
|
|
|
|
| BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
| FOXA / Fox Corporation
|
|
|
|
|
|
|
|
| HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
| KALA / KALA BIO, Inc.
|
|
|
|
|
|
|
|
| LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
| DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| AWI / Armstrong World Industries, Inc.
|
|
|
|
|
|
|
|
| PBYI / Puma Biotechnology, Inc.
|
|
|
|
|
|
|
|
| ECYT / Endocyte, Inc.
|
|
|
|
|
|
|
|
| TRN / Trinity Industries, Inc.
|
|
|
|
|
|
|
|
| SLM / SLM Corporation
|
|
|
|
|
|
|
|
| AVXS / AveXis, Inc.
|
|
|
|
|
|
|
|
| TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
| XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
| WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
| BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| SGEN / Seagen Inc
|
|
|
|
|
|
|
|
| ESRX / Express Scripts Holding Co.
|
|
|
|
|
|
|
|
| TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
| INCY / Incyte Corporation
|
|
|
|
|
|
|
|
| BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
| FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
| C / Citigroup Inc.
|
|
|
|
|
|
|
|
| MYOV / Myovant Sciences Ltd
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| GHDX / Genomic Health, Inc.
|
|
|
|
|
|
|
|
| ADS / Bread Financial Holdings Inc
|
|
|
|
|
|
|
|
| ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
| STX / Seagate Technology Holdings plc
|
|
|
|
|
|
|
|
| BRK.A / Berkshire Hathaway Inc.
|
|
|
|
|
|
|
|
| IFRX / InflaRx N.V.
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ABMD / Abiomed Inc.
|
|
|
|
|
|
|
|
| BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CBRE / CBRE Group, Inc.
|
|
|
|
|
|
|
|
| SMLP / Summit Midstream Partners, LP - Limited Partnership
|
|
|
|
|
|
|
|
| KKR / KKR & Co. Inc.
|
|
|
|
|
|
|
|
| AMZN / Amazon.com, Inc.
|
|
|
|
|
|
|
|
| SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
| COCP / Cocrystal Pharma, Inc.
|
|
|
|
|
|
|
|
| NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
| SPY / SPDR S&P 500 ETF
|
|
|
|
|
|
|
|
| IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
